FRCPath Haem Part 1 MCQ-Haemostasis 361

A TTP patient remains severely ADAMTS13 deficient despite PLEX, steroids, Caplacizumab and anti-CD20 therapy. What is the most appropriate next step?

• FFP Transfusion to increase ADAMTS13 level
• ADAMTS13 recombinant concentrate
• Add Antiplatelet
• Cyclophosphamide

See All Options

Want to read more?

Subscribe to hematomorph.com to keep reading this exclusive post.

Subscribe Now